Facial Melanosis: A Comprehensive Review of Uncommon and Common Presentations with Personal Experience Authors: Rashmi Sarkar, Damini Verma Published: 2026 ABSTRACT Facial melanoses (FMs) encompass a diverse group of disorders characterised by altered facial pigmentation, particularly prevalent in individuals with darker skin types, such as the Indian population. While common causes like melasma, post-inflammatory hyperpigmentation, and lichen planus pigmentosus are well documented in the literature, this review emphasises the lesser-known and uncommon causes of FM. These include facial acanthosis nigricans, maturational hyperpigmentation, frictional facial melanosis, and seborrheic melanosis, which are frequently observed in Indian populations but remain underrecognised and understudied. The aetiology of FM is multifactorial, involving genetic predisposition, racial factors, ultraviolet radiation, and exposure to photosensitising chemicals and allergens. Uncommon causes often present unique diagnostic challenges and are frequently misdiagnosed due to their overlapping clinical features. Diagnosis relies on clinical evaluation, supported by Wood’s lamp examination, dermoscopy, and, in some cases, skin biopsy. FM can be classified into brown, blue, or mixed hypermelanosis based on the location and nature of melanin deposition. Management of these uncommon conditions is complex and requires a nuanced approach. Photoprotection remains a cornerstone of therapy, alongside topical depigmenting agents, chemical peels, and laser or light-based interventions. However, the risk of post-inflammatory hyperpigmentation in richly pigmented skin necessitates cautious and individualised treatment strategies. The lack of standardised guidelines for these uncommon causes further complicates management, underscoring the need for tailored therapeutic approaches. This review highlights the clinical significance of recognising and addressing uncommon causes of FM, which significantly impact patients’ quality of life and psychosocial well-being. Enhanced awareness, further research, and the development of evidence-based treatment protocols are essential to improve outcomes for patients with these understudied conditions. By focussing on these uncommon causes, this review aims to fill a critical gap in the literature and provide a comprehensive resource for clinicians managing facial melanoses in skin of colour. Such comprehensive articles are lacking in literature. Introduction Facial melanoses (FMs) are a group of heterogeneous entities having the common feature of altered facial pigmentation. FMs are quite common in Indian patients, with both light and photosensitising chemicals playing an important role.[1] Genetic and racial factors are important, the increased pigmentation occurring more frequently in those with dark skins, especially those with Middle Eastern or Asian descent.[2] About 80% of the Indian population present skin colour heterogeneity over face, irrespective of age and gender.[3] While certain factors such as ultraviolet (UV) radiation in melasma, exposure to allergens in Riehl’s melanosis, and chemical exposure in erythema dyschromicum perstans (EDP) are well documented, the aetiology of many FM conditions remains poorly understood.[1] A fair skin is prized above a healthy even-toned facial skin especially in a tropical country like India, with facial pigmentation translating into a significant psychosocial problem and a frequent cause of dermatology consultation.[4] Skin disorders, especially those on face, unlike most internal illnesses, are often immediately visible to others and therefore may lead to significant psychosocial consequences, and consequent dermatological consultations, thus explaining the growing importance of these disorders. Some of the uncommon causes of FM in India are acanthosis nigricans, maturational hyperpigmentation, Addisonian pigmentation, seborrheic melanosis, facial frictional melanosis, pigmented transverse nasal band, and pigmentary demarcation lines [Table 1]. Table 1Uncommon causes of facial melanosis in IndiaUncommon Causes of Facial MelanosisAcanthosis nigricansMaturational hyperpigmentationAddisonian pigmentationSeborrheic melanosisFacial frictional melanosisPigmented transverse nasal bandPigmentary demarcation linePiokiloderma of civatte/ erythromelanosis interfollicularis ColliErythromelanosis follicularis of the face and neckPost chikungunya pigmentation Uncommon causes of facial melanosis in India Diagnosis is generally based on clinical features and helped by Wood’s lamp examination, dermoscopy, and skin biopsy.[15] This review focusses on uncommon acquired FM seen in Indian patients, as well as a few rare entities that are often overlooked in the literature. By highlighting these less common causes, we aim to provide a comprehensive understanding of their clinical presentation, diagnostic challenges, and management strategies, addressing a critical gap in the existing knowledge of facial melanoses. This review focusses on uncommon acquired FM seen in Indian patients, as well as a few rare entities that are often overlooked in the literature. By highlighting these less common causes, we aim to provide a comprehensive understanding of their clinical presentation, diagnostic challenges, and management strategies, addressing a critical gap in the existing knowledge of facial melanoses. This review focusses on uncommon acquired FM seen in Indian patients, as well as a few rare entities that are often overlooked in the literature. By highlighting these less common causes, we aim to provide a comprehensive understanding of their clinical presentation, diagnostic challenges, and management strategies, addressing a critical gap in the existing knowledge of facial melanoses. Uncommon Causes of Facial Melanosis Acanthosis nigricans AN is characterised by hyperpigmented, velvety thickening of skin predominantly affecting body folds such as neck and axilla. It can affect face as well in rare cases. Facial AN characteristically involves zygomatic and malar areas of face, the overlying skin being rough, dry, and verrucous. It is a commonly seen lateral aspect of face, forehead, and periorbital area. [Figure 1] It is often associated with AN of knuckles, neck, groin, and neck. It accounts for about 7.5% of numerous causes of facial melanosis. It is predominantly described in dark skin types like South Asians, Hispanic, and African population. Most of the cases develop in third to fifth decades. Males are most affected than females.[6] (Facial acanthosis nigricans): A 32-year-old male presenting with dark-brown diffuse pigmentation over his forehead It is often associated with metabolic derangements. Facial AN thus aids as an early clinical indicator of insulin resistance, metabolic syndrome, and diabetes mellitus.[7] The role of elevated growth hormone and pigment epithelium derived factor (PEDF) have been proposed to play an important role in pathogenesis of AN. It was also found that male patients, those with elevated homeostatic model assessment (HOMA2)- insulin resistance (IR) level, positive oral glucose tolerance test (OGTT), increased waist hip ratio (WHR), and increased BMI have a significantly higher probability of developing facial AN. Thus, a patient of FAN should be thoroughly evaluated for underlying systemic illness, even if there are no signs and symptoms present.[7] Facial AN needs to be differentiated from maturational hyperpigmentation (MH), facial frictional melanosis, pigment contact dermatitis (PCD), and exogenous ochronosis (EO). Life style modifications such as weight reduction play a pivotal role in management of facial AN. Symptomatic treatments include topical retinoids, vitamin D analogues, insulin sensitisers, and keratolytics. Chemical peels and lasers have been tried. Associated metabolic conditions should be ruled out. Maturational hyperpigmentation Maturational hyperpigmentation (MH) is a newly described facial melanosis. It presents as diffuse pigmentation that generally occurs on lateral forehead and cheekbones [Figure 2a and b]. These changes in the skin tone probably occur from chronic sun exposure over many years. This is a diagnosis of exclusion.[8] It is usually seen in middle-aged patients with darker Fitzpatrick skin phenotypes V and VI. Clinically, it is seen as asymptomatic granular hyperpigmentation with indistinct margins blending into the surrounding normal skin. It predominantly affects the sun-exposed areas of lateral face, especially the temple area and hollows of cheek. Fasting hyperglycaemia and hyperinsulinemia are seen in more than 70% of the patients suffering with MH, suggesting it a cutaneous marker of MH.[8] (Maturational hyperpigmentation): (a) A 35-year-old man presenting with dark-brown diffuse pigmentation over left temple extending over lateral malar area. (b) Dermoscopic examination revealed brown rings and clods with perifollicular accentuation (DermLite DL4; 10x) While facial AN and MH might be seen as evolutionary variants within the morphological spectrum of cutaneous markers of metabolic syndrome, considering them synonymous without dermoscopic or supportive evidence seems premature at this stage. Typical features, including a softer surface with fine granularity, indistinct margins in gross morphology, and unique dermoscopic and histopathological characteristics, suggest that MH should be recognised as a distinct nosological entity. Therefore, it is crucial for physicians to be aware of this subtle and less well-known asymptomatic condition to ensure timely investigation for metabolic syndrome.[9] Treatment includes the screening for metabolic syndrome along with the use of broad-spectrum sunscreens; skin lightening agents such as hydroquinone, kojic acid, and azelaic acids; retinoids; anti-oxidants; microdermabrasion; and/chemical peels.[10] Addisonian pigmentation Addisonian pigmentation typically occurs in primary adrenal insufficiency due to autoimmune adrenalitis, tuberculosis, metastatic malignant disease, sarcoidosis, amyloidosis, and congenital adrenal hypoplasia. Excessive production of β-MSH and ACTH by the pituitary due to low circulating levels of adrenocortical steroids has been implicated in pathophysiology.[11] It presents as brownish-black pigmentation, most pronounced on the sun-exposed areas such as face, areas subjected to repeated frictions (perineum, groin, and axilla), elbows and knuckles [Figure 3a and b], palmer and plantar creases, and recently acquired scars and nevi. Mucosal pigmentation is one of the most important features.[12] (Addisonian pigmentation): (a) A 36-year-old female presenting with diffuse brownish pigmentation over forehead, periorbital area, perioral rea, and chin. (b) Dermoscopic examination revealed accentuated pigment network (DermLite DL4; 10x) Addisonian pigmentation can be a manifestation of multiple systemic diseases; hence, an interdisciplinary approach is needed with extensive clinical and laboratory evaluation. Vitamin B 12 deficiency and tuberculosis is one of the most common causes of Addisonian pigmentation in the Indian population.[13] Seborrheic melanosis Seborrheic melanosis (SM) presents as localised darkening over seborrheic areas of the face like alar grooves, angle of mouth, and labiomental crease. Although the mechanism of pigmentation is not known, the proposed ones are: It can be a post-inflammatory hyperpigmentation post seborrheic dermatitis, or it can be due to a shadow effect of the ala nasi and overhanging lower lip.[14] This pigmentation pattern is commonly observed in individuals with darker skin tones from Asia, Africa, and the Hispanic population. It is found to be more common in females as compared to males. It is quite rare in children and women in the post-menopausal age group; this could be due to relative lack of sebum in children and a decrease in sebaceous gland secretion with advancing age group. It develops in the area that is prone for seborrheic dermatitis. The lesions start as scaling and erythema on the alar areas, angle of mouth, and labiomental crease, which is eventually followed by pigmentation in these areas. Some patients of SM have a relatively bulbous nose that makes alar groove prominent. This could be due to increased accumulation of sebum in these areas without an actual increase in the sebum production. Tendency to rub and use of cosmetics with irritation potential could be the additional factors for this condition. Dermatologists should recognise SM as it is resistant to conventional lightening agents. Initial treatment should focus on topical anti-inflammatory or fungistatic agents like calcineurin inhibitors, mild steroids, or 2% ketoconazole to reduce inflammation. Lightening agents, such as kojic acid, azelaic acid, or arbutin, can be introduced later.[15] Facial frictional melanosis Facial frictional melanosis (FFM) is a characteristic pattern of facial pigmentation that follows vigorous rubbing or cleaning of the face in Indian patients. It is seen predominantly but not exclusively in males. History of hyperhidrosis is a notable feature, seen in around 63.3% patients of FFM.[16] It is hardly uncommon but often goes misdiagnosed and remains largely unreported. It is usually secondary to vigorous rubbing due to a constant compulsive urge to wipe off the sweat and grime leading to pigmentation overlying bony prominences sparing the nose tip. It is postulated that squeezing of melanocytes against the underlying bony structures releases melanosomes to the dermis seen as melanophages after engulfment by macrophages, resulting in the pigmentation seen clinically at sites of friction. This resultant pigmentation leads to a paradoxical increase in the vigorous rubbing exacerbating the pigmentation and setting up a vicious cycle of friction and reactionary hypermelanosis. There is usually a distinct vertical linear band of sparing in the middle of forehead and sparing of apex of nose which stood out in contrast to the surrounding hypermelanosis [Figure 4]. The histological picture is of both epidermal and dermal melanosis.[16] (Frictional facial melanosis): Diffuse dark-brown pigmentation presents over forehead with a distinct vertical linear band of sparing present in the centre. Multiple, discrete, hyperpigmented, irregularly shaped macules suggestive of melasma also present over bilateral cheeks Effective treatment would include removal of friction by habit change to gentle mopping, use of sunscreens, and an array of exfoliating and depigmenting agents. The knowledge of typical clinical clues and alert history taking will aid the clinician to arrive at the diagnosis of FFM leading to its appropriate management. Pigmented transverse nasal band The pigmented transverse nasal band or groove is a benign, asymptomatic dermatological entity. An incidence of 0.3% has been reported in the Indian population, thus making it a relatively rare cutaneous disorder. This condition mostly affects adolescents and young adults with incidence peaking during the third decade. It becomes shallower with age. By the end of fifth decade, only a faint hyperpigmented transverse band can be seen. A female preponderance has been reported, and 15% familial incidence has been noted.[17] It is characterised by the appearance of 1–2 mm hyperpigmented, well-defined transverse groove at the junction between the middle and lower two-thirds of the nasal dorsum.[17] Although its exact cause is not fully understood, the most widely accepted theory points to an embryological origin. Its occurrence has been attributed to the under surface of the nasal bone by fibrous septae. This condition is frequently associated with other dermatological issues like milia, comedones, seborrheic dermatitis, and atopic dermatitis. It needs to be differentiated from other transverse lesions on the nose such as allergic rhinitis, seborrheic melanosis, and wrinkles of photoaging/chronological aging. Diagnosis is primarily clinical, with reassurance being the cornerstone of management. In cases where the condition persists or it is associated with milia and comedones, topical retinoids have been employed as a treatment option. Similarly, topical steroid may show some improvement if it is associated with seborrheic dermatitis. Pigmentary demarcation lines Pigmentary demarcation lines, also known as Futcher’s or Voight’s lines, are physiological, sharp transitions between deep and lighter pigmented skin.[18] Five types, labelled A–E, have been identified: A: On lateral aspect of upper arm extending over the pectoral region.B: On posteromedial portion of lower limb.C: Medio-sternal line, a vertical hypopigmented line along the pre- and parasternal area.D: On posteromedial spine area.E: Bilateral hypopigmented bands on the chest between the mid-clavicle and periareolar region. A: On lateral aspect of upper arm extending over the pectoral region. A: On lateral aspect of upper arm extending over the pectoral region. B: On posteromedial portion of lower limb. B: On posteromedial portion of lower limb. C: Medio-sternal line, a vertical hypopigmented line along the pre- and parasternal area. C: Medio-sternal line, a vertical hypopigmented line along the pre- and parasternal area. D: On posteromedial spine area. D: On posteromedial spine area. E: Bilateral hypopigmented bands on the chest between the mid-clavicle and periareolar region. E: Bilateral hypopigmented bands on the chest between the mid-clavicle and periareolar region. These lines have also been observed on the face in the Indian population, which are as follows [Figure 5a]:[19] (Pigmentary demarcation line): (a) Types of pigmentary demarcation lines over face in Indian population. (b) A 25-year-old woman presenting with ‘V’-shaped hyperpigmented patches on lateral aspect of face between the malar prominence and temple. These patches have merged with infraorbital pigmentation F: ‘V’- shaped hyperpigmented patches that appeared on the lateral aspect of face between the malar prominence and temple. These patches merge with infraorbital pigmentation in 20% of cases [Figure 5b].G: ‘W’- shaped hyperpigmented patches that appeared on the lateral aspect of face between the malar prominence and temple.H: Linear bands of hyperpigmentation extending from just below the angle of the mouth to the lateral aspects of the chin. F: ‘V’- shaped hyperpigmented patches that appeared on the lateral aspect of face between the malar prominence and temple. These patches merge with infraorbital pigmentation in 20% of cases [Figure 5b]. F: ‘V’- shaped hyperpigmented patches that appeared on the lateral aspect of face between the malar prominence and temple. These patches merge with infraorbital pigmentation in 20% of cases [Figure 5b]. G: ‘W’- shaped hyperpigmented patches that appeared on the lateral aspect of face between the malar prominence and temple. G: ‘W’- shaped hyperpigmented patches that appeared on the lateral aspect of face between the malar prominence and temple. H: Linear bands of hyperpigmentation extending from just below the angle of the mouth to the lateral aspects of the chin. H: Linear bands of hyperpigmentation extending from just below the angle of the mouth to the lateral aspects of the chin. All the above patterns are seen more clearly in people with wheatish complexion rather than those with a very fair or dark complexion. They make their appearance around puberty, may have a genetic predisposition, and tended to persist throughout life. In a study, about 6% of the population attending a skin clinic were found to have PDL. It was found to be more common in women (9%) than in men (0.75%).[19] They can often be misdiagnosed as melasma, post-inflammatory pigmentation, nevus of Ota or Ito, or melanocytic nevus. However, their appearance is distinctive enough to be recognised as a fairly common variant of normal pigmentation in the Indian population. It does not respond to treatment well. Tripple combination had been tried and was not effective. Chemical peels and q switched lasers had been tried with variable efficacy. Piokiloderma of civatte/erythromelanosis interfollicularis Colli Poikiloderma of Civatte, although rarely reported, is most commonly seen in middle-aged, postmenopausal Caucasian women, but its mild variant is not uncommon and has also been reported in individuals with skin of colour.[20] Photodynamic substances in cosmetics and fragrances, hormonal changes of menopause, and solar radiation may be implicated. Histopathological evaluation revealed thinning of the spinous layer, hydropic degeneration of the basal cell layer, presence of melanophages in the papillary dermis, and dilatation of the papillary dermal capillaries. Clinically, it presents as mottled hyperpigmentation and atrophic hypopigmentation with telangiectasia over the sun-exposed parts of face, neck, and V of the chest. It predominantly involves the convexities of face. Submental and submandibular areas are spared. It is mostly asymptomatic; some can experience itching, burning, and flushing. It is slowly progressive and irreversible, often causing significant cosmetic disfigurement.[21] Sun protection is centre to management with avoidance of cosmetics and perfumes. Intense pulse light laser and Ndyag laser have been tried. Erythromelanosis follicularis of the face and neck It primarily affects young or middle-aged males and sometimes in adult females. It affects all races, but it is mostly reported in Asians. It is associated with Keratosis pilaris. Its cause is unknown. It has shown familial predisposition also.[22] It is characterised by reddish-brown pigmentation and telangiectasia studded with pale follicular papules affecting the preauricular and maxillary regions and can spread to the temple and lateral side of the neck and trunk, with symmetrical distribution and sharp demarcation from normal skin. Alopecia characteristically affects fine vellus hair and spares the terminal hair. It spreads slowly and is persistent and not influenced by treatment.[23] Post chikungunya pigmentation Chikungunya fever (CF) is an acute illness characterised by fever, joint pain, and various other constitutional symptoms. It is caused by alpha virus and is transmitted by Aedes aegypti and Aedes slbopictus.[24] It can cause a range of mucocutaneous changes, including centrofacial freckle-like macules, diffuse hyperpigmentation on the face and extremities, flagellate pigmentation, mucosal hypermelanosis of the tongue and palate, pigmentation of existing acne, maculopapular rash, aphthous-like ulcers, transient nasal erythema, ecchymosis, and vasculitic lesions.[25] One notable feature is the distinct pigmentation over the nose, known as the ‘chik sign,’ which appears a few weeks after the fever subsides and can persist for 3–6 months after the infection.[26] Awareness of this pigmentary change is crucial for both physicians and dermatologists as it can serve as a marker for an unrecognised CF outbreak, particularly in healthcare settings where screening every viral fever case for CF is not feasible. Ephelides and lentigines Ephelides, or freckles, are the result of increased photoinduced melanogenesis and transport of an increased number of fully melanised melanosomes from melanocytes to keratinocytes. It occurs on sun-exposed areas of the body, particularly the face, dorsal hands, and upper trunk. There are 1–3 mm well-defined, hyperpigmented macules that are round, oval, or irregular in shape. They may increase in number and distribution and show a tendency for confluence, but they can fade in winters or overtime with aging.[27] Lentigines are 3 to 2 cm well-circumscribed, round, oval, or irregularly shaped macules or patches that vary in colour from tan to dark brown. They also occur on sun-exposed areas. Management includes photoprotective measures, skin-lightening agents, cryotherapy, and lasers.[27] Common Facial Melanosis Melasma Melasma is one of the most common acquired facial pigmentary disorder, predominantly seen in people of constitutionally darker skin types. It is quite common in Southeast Asian countries, especially India. It occurs mainly in women (90%) and 10% of males of all ethnic and racial groups. 20–30% of 40–65 years old women in India present with facial melasma.[28] While the exact aetiology of melasma is not known, several factors such as exposure to UV radiation, increased oestrogen levels (mainly during pregnancy or use of oral contraceptives), genetic predisposition, and exposure to phototoxic drugs are known to play an important role.[2930] It presents as light to dark brown or brown-gray patches with irregular borders primarily on the face, affecting the forehead, cheeks, nose, and upper lip sparing the filter and nasolabial fold and chin [Figure 6a and b]. On the basis of primary location of the pigment, melasma has been classified into epidermal, dermal, missed, or inderminate. Pigment accentuation is seen with Wood’s lamp in epidermal melasma.[31] (Melasma): (a) A 45-year-old woman presenting with multiple, discrete as well as confluent, hyperpigmented, irregularly shaped, brown macules present over forehead, nasal bridge, bilateral cheeks, and temporal area. (b) Accentuation of dark-brown-coloured pseudoreticular pigment network with perifollicular and peri appendageal sparing (DermLite DL4; 10x). Sun protection is central to management. Epidermal pigmentation is more responsive to topical treatments (hypopigmenting agents such as hydroquinone (HQ), tretinoin, azelaic acid, rucinol, cysteamine, and kojic acid) than dermal melasma. Chemical peels and lasers may be helpful.[32] Post-inflammatory hyperpigmentation Post-inflammatory hyperpigmentation (PIH) is an acquired facial melanosis that commonly results from various cutaneous insults, including drug reactions, phototoxic responses, infections, physical trauma, allergic reactions to cosmetic procedures, and inflammatory skin diseases. In fact, PIH is a very sequela after acne in dark-skinned individuals [Figure 7]. The incidence of PIH in individuals with dark skin tones with acne can be as high as 65%.[33] Flow chart depecting approach to facial melanosis Clinically, it appears as macular hyperpigmentation at the site of prior inflammation, particularly affecting individuals with darker skin tones (Fitzpatrick Types III–VI). PIH can manifest as both epidermal and dermal pigmentation. Recent updates indicate that newer treatments, including topical depigmenting agents, laser therapies, and chemical peels, are being explored to enhance outcomes in PIH management, though their effectiveness varies depending on the depth and cause of the pigmentation.[34] Acquired dermal macular hyperpigmentation The Delphi consensus recommended using “acquired dermal macular hyperpigmentation” as a unified term for dermatoses characterised by idiopathic or multifactorial non-inflammatory macular dermal hyperpigmentation.[35] It is an umbrella term that includes disorders clinically characterised by small and large pigmented macules/patches histopathologically showing an evidence of interface dermatitis with pigment incontinence, without clinically significant prior inflammatory phase. It includes lichen planus pigmentosus (LPP), Riehl’s melanosis/pigmented cosmetic dermatitis, and ashy dermatosis/erythema dyschromicum perstans[36] [Table 2]. These disorders share many clinicopathological similarities, are difficult to treat, and adversely affect the quality of life. Table 2Clinical similarities and differences between various causes of acquired dermal macular pigmentationCharacteristicsLPPRiehl’s melanosisAshy dermatosisEpidemiologyQuite common in IndiaReported primarily from Asia especially JapanQuite common in Mexico and rest of Latin worldAgeAny age but has younger age of onset as compared to PCDMiddle ageAetiologyMostly unknown Mustard oil, amla oil, cosmetics, hair dyes.Pigmented contact dermatitis to antigens present in cosmetics, fragrances, and textiles.Unknown Ammonium nitrite, radiographic contrast media, intestinal whipworm infestation, HIV infection, cobalt allergyMorphology• Discrete, dark grey to dark brown, oval macules that coalesce to form patches with well-defined margins• Site: Face, neck, trunk, and upper limb. Can be flexural• Perioral involvement is typical• Reticular, diffuse, or patchy hyperpigmented macules of variable colours (black, dark brown, pale brown, bluish purple)• Site: Bilateral symmetrical, more intense on forehead and temples, sometimes can extend to arms and shoulders• Well- to ill-defined, ash or blue grey or brown-coloured, macules or patches with elevated erythematous border occasionally.• Site: Face, neck, trunk, and upper limbPruritisMay be present rarelyUsually presentAbsentHistopathologya. Epidermal atrophyCan be seen in old lesionsOften presentOften presentb. HypergranulosisUsually presentAbsentAbsentc. Epidermal spongiosisAbsentMay be presentAbsentd. Basal cell damageUsually presentUsually presentUsually presente. Colloid bodyUsually presentMay be presentUsually presentf. Band-like lichenoid infiltrateUsually absent, but can be present in early lesionsAbsentAbsentg. Pigment incontinencePresent (superficial dermis)PresentPresent (mid to deep dermis)DermoscopyDark-brown and bluish grey dots and globules arrange in reticular, pseudo reticular, hem-like pattern due to perifollicular and peri eccrine pigment incontinence. Peri appendageal pigment accentuation• Brown and blue-grey pigment globules in a pseudo reticular pattern (globules are fines and smaller than LPP)• Superimposition of brown dots – characteristics• Other features: telengiectasias, follicular plugs, and perifollicular halo (due to follicular hyperkeratosis and perifollicular fibrosis)• Small grey-blue dots and globules irregularly organised in a linear and circular design- speckled or sprinkled appearance (pigment granules of EDP more intense in colour and bigger in size due to deeper pigment localisation)• No pseudoreticular/ reticular pattern and periappendageal distribution• Large irregular vessels can be seenAssociationsLichen planus, thyroid disorder, vitiligo, alopecia areataNoneNoneManagement• Avoidance of exacerbating factors; photoprotection, and measures to reduce friction in the inversus variant such as weight reduction and avoidance of tight clothes.• Topical steroids, topical tacrolimus, low fluence Q-switched NdYag laser – doubtful efficacy• Systemic modalility – Systemic corticosteroids, dapsone, colchicine, and isotretinoin. Mycophenolate mofetil (2 g/day) has been tried by few and was efficacious.• Treatment remains inconclusive.• Avoidance of causative agents.• Treatment options with doubtful efficacy: hydroquinone, tretinoin, glycolic acid, NdYag laser, oral tranexamic acid.• For ashy dermatosis, no consistently efficacious treatment exists.• The successful outcomes obtained with griseofulvin and dithiazamine iodideseem anecdotal.• clofazimine was reported to provide promising results by some. Clinical similarities and differences between various causes of acquired dermal macular pigmentation Lichen planus pigmentosus LPP was first described by Bhutani et al.[37] as a clinical entity. It is quite common in the Indian population, although the precise figures of its incidence and prevalence have not been established. Although its exact aetiology is not known till date, cosmetics, mustard oils (contains allyl thiocyanate, a potential photosensitiser), henna, and hair dyes have been incriminated.[38] It is characterised by generally bilaterally symmetrical asymptomatic (sometimes itchy) and diffuse (less frequently blotchy, reticular, or perifollicular) hyperpigmented dark-brown to slate-grey to black macules present mostly overexposed areas (face and neck) and flexures [Figure 8a and b].[1] (Lichen planus pigmentosus): (a) A 47-year-old woman presenting with diffuse slate-grey to dark-brown macules present mostly over the exposed part of her face including the neck. (b) Diffusely distributed dark-brown to grey dots and globules showing perifollicular accentuation in some areas (DermLite DL4; 10x) Riehl’s melanosis/pigmented cosmetic dermatitis Riehl’s melanosis is a phototoxic pigmented contact dermatitis to antigens present in cosmetic products, red and yellow pigments present in textile dyes, tar derivatives, and fragrances. In Indian patients, contact sensitisation to para-phenylenediamine in hair dyes is an important aetiological factor.[39] It is found to be more common in middle-aged women. Brownish-grey pigmentation develops quite rapidly over the lateral part of face rather than the centrally. It is more intense on the forehead and temple, and it may extend to ears, chest, neck, and scalp, and occasionally involves the hands and forearms. The skin surface looks slightly scaly, thickened, and rough. Horny plugs can be seen in widened follicular orifices on the forehead, cheeks, and ears.[40] Ashy dermatosis/erythema dyschromicum perstans Although EDP has been reported from many countries including India, it is most common in Latin America and Asia. It occurs in both sexes but causes greater concern in women, especially those of less than 30 years of age. The aetiology of EDP is unknown, but anecdotal reports have incriminated exposure to ammonium nitrite, chlorothalonil, radiographic contrast media, intestinal whipworm infestation, cobalt allergy, and HIV infection. Both EDP and LPP have several clinical, histological, and immunohistochemical similarities and often coexist making some authors consider EDP a variant of LP.[41] EDP lesions are asymptomatic and rarely pruritic. They present as numerous gradually enlarging and coalescing, persistent macules of variable sizes. Initially, they have an erythematous hue and an elevated dusky border (not always noted); lesions eventually become pigmented. Initially localised, it can eventually progress to involve extensive areas of face, trunk, and limbs. Palms, soles, scalp, and mucous membranes are usually spared. Once developed, the dermatosis is stable but may disappear spontaneously or subside within 2–3 years.[42] Peribuccal pigmentation of BROCQ It is predominantly seen in middle-aged women. A photodynamic substance in cosmetic is probably responsible. It presents as diffuse brown-red pigmentation present symmetrically around the mouth, with sparing the vermillion border. It may extend up to the temples, forehead, and angles of the jaw [Figure 2]. Pigmentation is persistent unless the offending agent is removed; however, the erythema may fluctuate.[43] Apart from peribuccal pigmentation of broq, perioral pigmentation could be due to allergic manifestation to food, saliva, toothpaste, cosmetics, and so on.[44] Periorbital hyperpigmrntation Periorbital hyperpigmentation (POH) is also known as periorbital melanosis, dark circles, or infraorbital darkening. In an Indian study, POH was found to be most prevalent in the age group of 16 to 25 years and was more prevalent in women.[45] The causative factors include genetic or heredity, excessive pigmentation, post-inflammatory hyperpigmentation secondary to atopic and allergic contact dermatitis, periorbital oedema, excessive vascularity, and shadowing due to skin laxity and tear trough associated with aging.[46] Clinically, it is characterised by light- to dark-coloured, brownish-black pigmentation surrounding the eyelids [Figure 9]. Manual stretching of the lower eyelid skin can help to differentiate between the dark eyelid skin with shadowing due to tear trough. Although the former retains its appearance with stretching, the latter improves or resolves entirely. On manual stretching of the lower eyelids, an increase in violaceous discolouration is due to thin eyelid skin or hypervascularity of lower eyelid.[47] (Periorbital hyperpigmentation): 4 - A 28-year-old woman presenting with dark-brown pigmentation around the eyes Although it is less responsive to standard therapies due to its multifactorial origin, even a mild to moderate improvement in appearance has a huge impact on the quality of life and can be achieved by topical therapies and simple physical therapies such as chemical peels and lasers. Nevus of OTA Nevus of Ota (NOO) or oculodermal melanocytosis is more common in Japanese women with onset either in the perinatal period (50%) or around puberty (30%).[48] Due to aborted embryonic migration of melanocytes from neural crest to epidermis, pigmentation of the amelanotic nevoid cells present at birth by adolescent spurt of sex hormones explains the late pubertal onset. The characteristic grey-blue hyperpigmentation occurs due to entrapped melanocytes.[49] It is characterised by speckled or mottled coalescing blue-grey pigmentation of the area supplied by ophthalmic and maxillary divisions of trigeminal nerve. It is usually unilateral (90%). It may involve oral mucosa and the eye (conjunctiva, sclera, cornea, retrobulbar fat, and retina) in which two levels of pigmentation – brown of conjunctiva and blue of sclera (often not overlapping) – are clearly discernible. Variants: Hori nevus, or acquired bilateral nevus of Ota-like macules (ABNOM): It is probably a distinct variant seen in Koreans and Japanese that has a late onset in adulthood, and spares the mucosae. ABNOM confined only to the malar area can mimic the centrofacial type of melasma clinically; however, fusiform-elongated dendritic melanocytes and melanophages are seen histopathologically.[50] Although NOO persists, it is only rarely complicated by melanoma and is anecdotally associated with ipsilateral glaucoma. Exogenous ochronosis Exogenous ochronosis (EO) is a facial melanosis characterised by blue-black pigmentation that is thought to be a complication of the long-term application of skin-lightening creams containing, in particular, hydroquinone (HQ) especially in skin of colour.[51] It is thought to occur due to deposition of homogenistic acid (ochre-coloured pigment) in the skin, although the exact mechanism is still unknown. The risk of EO increases if the concentration of HQ is greater than 2%, especially in alcoholic solution. It is characterised by asymptomatic blue-black macules on photo-exposed areas, especially malar area, temples, lower cheeks, and neck.[52] EO can be clinically mistaken for other acquired facial melanosis, and this misdiagnosis of EO leads to further prescription of topical depigmenting agents resulting in a vicious cycle which further aggravates the hyperpigmentation. The actual incidence of EO is quite low in the Indian population, despite the common use of such agents, which might be due to underreporting or lack of general awareness. Clinical should be aware of the existence of this condition and appropriately educate the patients to stay away from OTC drugs.[53] Approach to Facial Melanosis Diagnosis The approach to FM necessitates a thorough clinical evaluation, encompassing the identification of aetiological factors and the implementation of individualised treatment protocols. Diagnostic dermatoscopic features of various FM are given in Table 3. A detailed flowchart, presented in Figure 7, systematically delineates this approach to facilitate its application in clinical practice. Table 3Dermatoscopic features of various facial melanosesFacial melanosis causesDermatoscopic featuresMelasma• Accentuation of pseudoreticular pigment network with perifollicular and peri appendageal sparing.• Light to dark brown pigment depending upon depth of melanin• Brown and grey dots and globules• Increased vascularity (telangiectasia and erythema) in long standing untreated cases.Lichen planus pigmentosus• Dark-brown and bluish-grey (intense colour) dots and globules arranged in reticular, pseudoreticular, hem like, arcuate, speckled, and ring-like pattern• Peri appendageal pigment accentuation.• Absence of Wickam’s striaeRiehl’s melanosis• Brown and blue-grey pigment globules in pseudoreticular pattern (globules are smaller and finer than LPP)• Superimposition of brown globules – characteristic• Other features: telangiectasias, follicular plugs, and perifollicular white halos (due to follicular HK, and perifollicular fibrosis).Ashy dermatosis/erythema dyschromicum perstans• Small grey-blue dots and globules irregularly organised in a linear and circular design – speckled or sprinkled appearance. (Granules are intense in colour and bigger in size as compared to those of LPP due to well preserved and finger-like rete ridges, less melanin incontinence, and no active interface dermatitis.• Pseudoreticular/reticular pattern is not observed.• No predeliction for perifollicular or periappendageal region• Linear irregular vessels seen.Peribuccal pigmentation of brocq• Dark-brown reticular or hem-like pattern can be seen. Brown-coloured dots and globules can be seenPiokiloderma of civatte/ erythromelanosis interfollicularis Colli• Combination of linear and dotted vessels, areas of linear telangiectasias forming rhomboidal or polygonal vascular structures.• Light-brown structureless dots and globules.• White keratotic follicular plugsErythromelanosis follicularis of the face and neck• Multiple round whitish areas with keratotic follicular plugs surrounded by blue-grey spots or peppering in a reddish-brown background.Nevus of Ota• Bluish-grey structureless areas in patchy distribution• Scattered brown-grey dotsExogenous ochronosis• Dark greyish-brown globules arranged in annular and arciform pattern giving curvilinear and worm-like structures at places.• Brown amorphous structures obliterating the follicular openings• Confetti like de pigmentation• Multiple telangiectasiasAcanthosis nigricans• Linear crista cutis and sulcus cutis• Crista cutis – uplifted and pigmented epidermis by papillomatous projections• Sulus cutis – white colour due to basket weave stratum corneum filled in the valley of downwardly progressed epidermis.• Hyperpigmented dots in crista cutis• Severe AN show rhomboid (diamond)-shaped islands.Pigmentary demarcation line• Abrupt transition between pigmented skin and normal skin.• Prominent pseudo reticular pattern• Brown globules unevenly distributedMaturational dyschromia• Brown rings and clods with perifollicular accentuation.Addisonian pigmentation• Accentuated pigmentary networkSeborrheic melanosis• Prominent pseudonetwork• Linear and arborizing vessels over light pink background• Whitish yellow excresences erupting from vellus hair• Dilated follicular openings with plugsFrictional melanosis• Accentuated pseudo-pigment network• Irregularly placed pigment globules (patchy pigment incontinence)• Patulous follicular openings (due to repeated rubbing)Post chikungunya pigmentation• Prominent pseudo reticular pigment network with perifollicular sparing• Patulous follicular openings• Brown background with a few dark-brown to grey dots and globules.Ephelides• Reticular pattern with moth eaten edgesLentigines• Uniform structureless macules with sharply demarcated borders Dermatoscopic features of various facial melanoses Management FM is predominantly a benign condition that arises from a combination of endogenous and exogenous factors that influence melanocyte function and melanin synthesis. Management is broadly composed of strict photoprotection, broad spectrum sunscreens, topical and systemic therapies, chemical peels, and laser or light-based interventions [Table 4]. Table 4Treatment options for melasma and other facial melanosesDepigmenting agentsMechanism of actionUseDisadvantagesStrength of Recommendation Taxonomy (SORT)[54]Hydroquinone (HQ) and combinations• Inhibit tyrosinase activity• Promote melanocyte destruction• Promote degradation of melanosomes• Gold standard for melasma and other FM, particularly epidermal type.• Concentration available: 2-10%.• HQ in combination with retinoic acid (RA) and fluocinolone acetonide (Tripple combination [TC]) or with glycolic acid (GA) more effective• Response in melasma becomes evident in 5–7 weeks, can be continued up to 3–12 months.Erythema, burning, pruritis, desquamation Hydroquinone halo OchronosisAAzelaic acid (AA)• Inhibit tyrosinase activity• Selective antiproliferative and cytotoxic effects on melanocytes• AA has been used for melasma and other FM• AA 20% as effective as 4% and superior to 2% HQ• Can be combined with RA and 15–20% GA.Transient erythema, irritation, pruritis, dryness, burningBKojic acid• Inhibit catecholase activity of tyrosinase• It Is modestly efficacious when used alone in combination of 1–4%.• Quite efficacious in combination therapy in FM as it can be combined with HQ, GA and other depigmenting agent.Transient erythema Risk of contact dermatitisBRetinoids• Vitamin A derivative• Increase epidermal cell turnover• Express anti-inflammatory properties• All topically available retinoids viz., RA, adapalene, and tazarotene have been used in Melasma and other FM, either in monotherapy or in combination with HQ, steroid or other agents.• Oral isotretinoin has been tried in lichen planus pigmentosus with variable efficacy.Burning, dryness Retinoid dermatitis Risk of post-inflammatory hyperpigmentationBTrenexamic acid (TXA)• Inhibits UV-induced plasmin activity and impairs melanogenesis• Both oral (250 mg twice daily for 3 months) and topical formulations (2-5%) of TXA have been used for the management of melasma and other FM• Oral TXA can be used as monotherapy as well as in combination with other depigmenting agents, chemical peels or laser therapy.• Side effect better as compared to other depigmenting agents.• Erythema, scaling, dryness• Oral side effects include abdominal discomfort, bloating, headache, hypomenorrhea• Risk of thrombotic events in specific populations such as those with history of thrombolic disorders and pregnant femalesBCysteamine• Inhibit tyrosinase and peroxidase• Chelate metal ions required for melanin synthesis• Scavenging dopaquinone• Its 5% topical formulation has been found as effective as or even better than HQ and TC in clearing melasma• Transient dryness, burning• MalodorousBGlycolic acid• Inhibits tyrosinase• Epidermal remodelling and accelerated desquamation• Can be used in combination for melasma and other FM• Irritation• ErythemaLesser used agents Niacinamide, Mequinol, arbutin, ascorbic acid, liquiritin, etc• These agents predominantly inhibit tyrosinase or have antioxidant properties.• Can be used in combination with other depigmenting agents• These compounds can be considered for patients preferring a natural treatment option for their PIH or melasma in addition to photoprotection and behavioural modification.• These agents are generally well tolerable; however, long-term studies are lackingChemical peels: glycolic acid, salicylic acid, azelaic acid, Jessner solution, trichloroacetic acid• Causes controlled destruction of the skin layers• Enhances keratinocyte turnover, leading to the shedding of damaged skin cells• Targets hyperpigmented areas, improving skin texture, and reducing the appearance of dark spots over time in FM• It stimulates collagen production and accelerates cell regeneration helping in achieving even skin tone and minimising visibility of pigmented skin.• Post-inflammatory pigmentary changes• Burns, erythema, irritation,• Desquamation• ScarringB Laser Ablative laser• Causing controlled damage of the skin layers, allowing for precise targeting of hyperpigmented areas• Can be used in resistant cases of FM with other modalities of treatment• Post-inflammatory pigmentary• Changes, Burns, erythema, irritation,• ScarringNot recommendedNon ablative fractioning laser• Creates controlled thermal damage within dermis• Causes melanin extrusion• FM cases resistant to other modalities• Risk of post-inflammatory pigmentary changes in darker skin tones• Burns, erythema, pain• Requires optimisation based on patient’s skin typeBLow fluence Q switched laser• It selectively destroys melanin pigments• Quite efficacious in Nevus of Ota• Can be used in lichen planus pigmentosus, PDL, and other resistant FM cases.• Risk of post-inflammatory pigmentary changes in darker skin tones• Burns, erythema, pain• Requires optimisation based on patient’s skin typeB Treatment options for melasma and other facial melanoses When treating skin of colour, it is crucial to account for biological differences that may affect treatment outcomes. Topical therapies remain the first-line treatment, with hydroquinone as the gold standard, either as monotherapy or in combination with other agents. For patients who do not respond to either hydroquinone or other depigmenting agents, second-line treatment options include chemical peels, either alone or in combination with topical therapies. Maintenance therapy is often necessary to sustain remission, with a combination of topical agents being advisable.[54] Chemical peels and laser or light-based treatments are valuable adjuncts but require careful application in richly pigmented skin due to the heightened risk of post-inflammatory hyperpigmentation. Currently, there are no established guidelines for managing other forms of facial melanosis. The heterogeneous nature of these conditions, along with the variability in treatment assessment, makes it challenging to compare outcomes effectively. Conclusion FMs represent a significant dermatological concern, particularly in individuals with skin of colour, such as the Indian population. The lack of specific management guidelines for uncommon causes of FM, such as facial acanthosis nigricans, maturational hyperpigmentation, frictional facial melanosis, and seborrheic melanosis, adds to the complexity of their diagnosis and treatment. These conditions, though frequently observed in Indian skin, remain underrecognized and poorly understood, often leading to diagnostic challenges and suboptimal management. This review underscores the diverse and unique manifestations of uncommon facial melanoses, emphasizing the need for heightened clinical awareness and a deeper understanding of their etiopathogenesis. By shedding light on these lesser-known conditions, the review aims to bridge the gap in the existing literature and provide a comprehensive resource for clinicians. The conclusion highlights the critical importance of developing tailored management strategies that address the distinct clinical presentations and therapeutic challenges encountered in the Indian population. Enhanced research efforts, standardised diagnostic criteria, and evidence-based treatment protocols are essential to improve patient outcomes and alleviate the psychosocial burden associated with these conditions. Ultimately, this review calls for a more nuanced and individualised approach to the management of uncommon facial melanoses, ensuring better care for patients with skin of colour. Consent An informed consent has been taken from the patient’s guardian to publish the case details as well as photographs. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Conflicts of interest There are no conflicts of interest.